Bloodstream Infections and Infective Endocarditis — Written Clinical Reasoning

Model answer — Part A: S. aureus bacteraemia on haemodialysis

Frame the problem first. This is healthcare-associated S. aureus bacteraemia with the tunneled catheter as the presumed source — a catheter-related bloodstream infection supported by the paired line and peripheral cultures — and SAB is never benign: mortality approaches one in five, and management follows its own discipline [1] [2].

Immediate assessment: sepsis severity and haemodynamic status; examination for metastatic seeding (spine, joints, epidural space — ask specifically about back pain); review for prosthetic material and devices; repeat blood cultures at 24–48 hours to document clearance, because persistent positivity declares complicated disease [1] [4].

The catheter: S. aureus is a mandatory-removal organism. Remove the tunneled catheter, establish temporary non-tunneled access for dialysis, and do not attempt salvage with lock therapy — that option exists for coagulase-negative staphylococci and selected gram-negatives, not S. aureus [2].

Antimicrobials: empirical vancomycin only until susceptibilities return; once MSSA is confirmed, switch to flucloxacillin 2 g IV 4–6 hourly (or cefazolin) because beta-lactams outperform vancomycin for MSSA bloodstream infection [5].

Echocardiography and consultation: haemodialysis dependence is a risk feature pushing toward transoesophageal echo, and an infectious diseases consult measurably improves mortality and adherence to echo and duration standards [3].

Duration reasoning: two weeks of intravenous therapy only if every uncomplicated criterion holds — source removed, no endocarditis on echo, no prosthetic material, defervescence within 72 hours, negative follow-up cultures, no metastatic foci. In a dialysis patient with catheter-related SAB, practise as four weeks unless the full uncomplicated checklist is demonstrably satisfied [1] [4].

Model answer — Part B: fever, new murmur and an embolus

Diagnostic reasoning (apply Duke out loud): she already satisfies two major criteria — viridans streptococci from two separate culture sets, and new valvular regurgitation (the new early diastolic murmur) — plus minor criteria of fever, predisposing valve disease and a vascular phenomenon (the embolic cold toe). That is definite infective endocarditis before the echo report arrives; the echocardiogram now stages the disease rather than making the diagnosis [6].

Initial management: ensure three culture sets were taken before antibiotics and hold antibiotics until they are (if not yet given); transthoracic echo promptly with transoesophageal echo to define vegetation size and exclude periannular extension; assess the toe embolus (vascular status, Doppler/angiography as indicated); screen for other complications — fundi, urine dipstick for haematuria, neurological examination [6] [8].

Antimicrobials: for subacute native-valve streptococcal disease, benzylpenicillin or ceftriaxone 2 g IV daily for 4 weeks from the first negative culture, de-escalated from any broader empirical cover once susceptibilities return; if she remains stable, afebrile and echo-clean after at least 10 days, POET supports completing the course with an oral two-drug regimen [8] [9].

Surgical triggers to state explicitly: heart failure from valve dysfunction; uncontrolled infection (abscess, persistent bacteraemia, enlarging vegetation); and prevention of embolism — she has already embolised, so a vegetation greater than 10 mm after an embolic event moves her into surgical territory, and early surgery in this setting reduces the composite of death and systemic embolism [7].